Lacktman Comments on Findings of Foley Survey on the Use of Telemedicine Services
November 16, 2017
Healthcare Informatics
Partner Nate Lacktman is quoted in a Healthcare Informatics article, “Survey Indicates Major Jump in Telemedicine Adoption in Past Three Years,” about the findings of Foley’s 2017 Telemedicine and Digital Health Survey.
The findings, based on responses from more than 100 hospitals, specialty clinics, ancillary services and related organizations, reflect a surging demand for telemedicine-based offerings among providers and patients, and a broader acceptance of the technology by other major players in the health care industry in the three years since the inaugural survey was conducted in 2014.
“The pendulum has swung to really embrace telemedicine, which wasn’t close to being adopted and implemented on this scale when the respondents were first surveyed in 2014,” Lacktman said. “Health care providers, entrepreneurs, and patients alike have realized the potential to improve the quality of care in a more convenient, cost-effective manner which, in turn, has put pressure on the payer community to evolve their reimbursement strategies.”
The findings, based on responses from more than 100 hospitals, specialty clinics, ancillary services and related organizations, reflect a surging demand for telemedicine-based offerings among providers and patients, and a broader acceptance of the technology by other major players in the health care industry in the three years since the inaugural survey was conducted in 2014.
“The pendulum has swung to really embrace telemedicine, which wasn’t close to being adopted and implemented on this scale when the respondents were first surveyed in 2014,” Lacktman said. “Health care providers, entrepreneurs, and patients alike have realized the potential to improve the quality of care in a more convenient, cost-effective manner which, in turn, has put pressure on the payer community to evolve their reimbursement strategies.”
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 6, 2025
In the News
Louis Lehot Comments on Crypto Company IPO – 'Definitely a home run'
Foley & Lardner LLP partner Louis Lehot commented on the initial public offering of stablecoin issuer Circle in the Law360 article, "Circle's Smash IPO Could Pave Way For More Crypto Listings."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."